AACR-Kure It Research Grant for Immunotherapy in Kidney Cancer
April 17, 2018 - Grant recipient must attend the Grants Reception and Dinner to formally accept the grant. Grant funds may be used to support the grantee's registration and attendance at this Annual Meeting.
The AACR-Kure It Research Grant for Immunotherapy in Kidney Cancer represents a joint effort to promote and support innovative cancer research. This grant is available to full time, independent junior and senior investigators to study immunological aspects of, or treatments for, kidney cancer. Research projects should advance the basic knowledge of tumor immunology mechanisms, or develop new concepts in the treatment, control, or prevention of kidney cancer by immunology-based therapeutic approaches. Proposed projects may be basic, translational, clinical, or epidemiological in nature and must focus on cancer immunology including, but not limited to: immune recognition, regulation, tumor escape, and therapeutic manipulation for kidney cancer.
Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical immunology research who have promising ideas and approaches that can be applied to kidney cancer research. A track record of research in this specific field is not a requirement for funding.
The grant provides $250,000 over two years ($125,000 per year) for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators (grant recipient/collaborator salaries limited to 25% of the total grant), postdoctoral or clinical research fellows, graduate students and/or research assistants, research/laboratory supplies, equipment, travel, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.
Proposals will be accepted for new ideas and approaches with an immunological basis directly relevant and applicable to kidney cancer. Proposed research projects may be basic, clinical, translational, or epidemiological in nature and must focus on cancer immunology including, but not limited to: immune recognition, regulation, tumor escape, and therapeutic manipulation of kidney cancer.
Applications are invited from researchers currently in the field, as well as from investigators with experience in other areas of cancer or biomedical immunology research who have promising ideas or approaches that they will directly apply to kidney cancer. However, the applicability of the proposed project to kidney cancer must be fully described. A track record of research in this specific field is not a requirement for funding.
Submission of proposals that are duplicative of projects currently funded by Kure It (see www.kureit.org/cancer-research/current-research-funded.html) should be avoided.
Applicants must have a medical and/or doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in a related field and not currently be a candidate for a further terminal degree.
Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical or research institution anywhere in the world.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible. Employees or subcontractors of a U.S. government entity or for-profit private industry may serve as Collaborators, but no grant funds may be directed towards these individuals.
Any individual who currently holds an active AACR grant or a Kure It grant may not apply. Past grantees may apply if they complied with all progress and financial report requirements.
Investigators may submit only one application for the AACR-Kure It Research Grant for Immunotherapy in Kidney Cancer but may concurrently apply for other AACR grants. However, applicants are expected to accept the first grant they are awarded. Individuals may accept and hold only one AACR grant at a time.
Members of the Scientific Review Committee are not eligible to apply for a AACR-Kure It Research Grant for Immunotherapy in Kidney Cancer.
There are no citizenship or geographic requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.
AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active Membership by Thursday, February 15, 2018. The application will be applied to 2018 membership dues. Applications may be submitted using the Official Application for Membership online or downloaded as a PDF and submitted to the AACR office with the required documents.
AACR requires applicants to submit an electronic application by noon, U.S. Eastern Time on Thursday, February 15, 2018, using the proposalCENTRAL website at https://proposalcentral.altum.com.
Program Guidelines and Application Instructions are available in PDF format.